BioVendor – Laboratorni Medicina as:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:BioVendor - Laboratorni Medicina as - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10891
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:チェコ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
BioVendor – Laboratorni Medicina as (BioVendor) is a developer and manufacturer of immunoassays, recombinant protiens, antibodies and endotoxin-removal products. The company provides products such as immunoassays, proteins, antibodies, endotoxin removal products, endotoxin detection products, immuno-histochemistry, cell-based assays and colorimetric assays, among others. Its products are used in animal studies, apoptosis, asthma and allergic rhinitis, atherosclerosis, autoimmunity, blood pressure regulation and no metabolism, bone and cartilage metabolism, cardiovascular disease, cell adhesion proteins and research applications, among others. BioVendor markets its products through a network of distributors in Andorra, Belgium, Cyprus, Denmark, Finland, France, Greece, Greenland, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, the Netherlands, Norway, Portugal, Spain, Sweden, the Czech Republic and the UK, among others. BioVendor is headquartered in Brno, the Czech Republic.

BioVendor – Laboratorni Medicina as – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
BioVendor – Laboratorni Medicina as, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
BioVendor – Laboratorni Medicina as, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
BioVendor – Laboratorni Medicina as, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
BioVendor – Laboratorni Medicina as, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
BioVendor – Laboratorni Medicina as, Medical Devices Deals, 2012 to YTD 2018 9
BioVendor – Laboratorni Medicina as, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
BioVendor – Laboratorni Medicina as, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
AIT Austrian Institute Enters into Co-Development Agreement with BioVendor and Scienion 11
Licensing Agreements 12
BioVendor Enters into Licensing Agreement with Atlantic Cancer Research Institute 12
Acquisition 13
Anteo Diagnostics Sells DIAsource to BioVendor for USD19 Million 13
Anteo Diagnostics Completes Acquisition of DIAsource for USD16.7 Million 14
BioVendor – Laboratorni Medicina as – Key Competitors 15
BioVendor – Laboratorni Medicina as – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
BioVendor - Laboratorni Medicina as, Pharmaceuticals & Healthcare, Key Facts 2
BioVendor - Laboratorni Medicina as, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
BioVendor - Laboratorni Medicina as, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
BioVendor - Laboratorni Medicina as, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
BioVendor - Laboratorni Medicina as, Deals By Therapy Area, 2012 to YTD 2018 8
BioVendor - Laboratorni Medicina as, Medical Devices Deals, 2012 to YTD 2018 9
BioVendor - Laboratorni Medicina as, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
AIT Austrian Institute Enters into Co-Development Agreement with BioVendor and Scienion 11
BioVendor Enters into Licensing Agreement with Atlantic Cancer Research Institute 12
Anteo Diagnostics Sells DIAsource to BioVendor for USD19 Million 13
Anteo Diagnostics Completes Acquisition of DIAsource for USD16.7 Million 14
BioVendor - Laboratorni Medicina as, Key Competitors 15
BioVendor - Laboratorni Medicina as, Subsidiaries 16

List of Figures
BioVendor - Laboratorni Medicina as, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
BioVendor - Laboratorni Medicina as, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
BioVendor - Laboratorni Medicina as, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
BioVendor - Laboratorni Medicina as, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
BioVendor - Laboratorni Medicina as, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
BioVendor - Laboratorni Medicina as, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
BioVendor - Laboratorni Medicina as, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
BioVendor - Laboratorni Medicina as, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
BioVendor - Laboratorni Medicina as, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[BioVendor – Laboratorni Medicina as:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • HHV Solar Technologies Ltd:電力:M&Aディール及び事業提携情報
    Summary HHV Solar Technologies Ltd (HHV Solar), a subsidiary of Swelect Energy Systems Ltd, is a renewable energy company that manufactures and markets silicon photovoltaic solar modules. The company's modules include monocrystalline solar photovoltaic modules, multi-crystalline solar photovoltaic m …
  • Northbridge Financial Corporation:企業の戦略的SWOT分析
    Northbridge Financial Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • Egyptian General Petroleum Corporation:石油・ガス:M&Aディール及び事業提携情報
    Summary Egyptian General Petroleum Corporation (EGPC), formerly General Petroleum Authority, is engaged in the oil and gas exploration services. The company is engaged in the refining, production, drilling, transportation and storage of crude oil; production of lubricants and greases; provides man p …
  • Bosch Packaging Technology GmbH:企業の戦略・SWOT・財務情報
    Bosch Packaging Technology GmbH - Strategy, SWOT and Corporate Finance Report Summary Bosch Packaging Technology GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Intermountain Healthcare Inc:企業の戦略的SWOT分析
    Intermountain Healthcare Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Synthos SA:企業の戦略的SWOT分析
    Synthos SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • M. Dias Branco SA Ind Com de Alimentos:企業の戦略・SWOT・財務情報
    M. Dias Branco SA Ind Com de Alimentos - Strategy, SWOT and Corporate Finance Report Summary M. Dias Branco SA Ind Com de Alimentos - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Eolus Vind AB (EOLU B):企業の財務・戦略的SWOT分析
    Summary Eolus Vind AB (Eolus Vind) is a wind farm developer that offers construction, development, and operation of green field projects and wind power plants. The company offers services such as consultancy services, administration, financing, development, and management of wind farms. It also offe …
  • CGN Power Co Ltd (1816):電力:M&Aディール及び事業提携情報
    Summary CGN Power Co Ltd (CGN Power) a subsidiary of China General Nuclear Power Corp, is an electric utility. It generates and sells nuclear power and provides services. The company produces electricity using nuclear source. Under electricity sales contracts, CGN Power sells energy. It also has int …
  • Ipsen SA (IPN):企業の財務・戦略的SWOT分析
    Ipsen SA (IPN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Erasmus MC-医療機器分野:企業M&A・提携分析
    Summary Erasmus MC (Erasmus) is a medical institute that offers patient care, research and educational services. The institute offers graduate and doctoral programs in health sciences, biomedical sciences, molecular medicine and cardiovascular sciences. It conducts research in the areas of biochemis …
  • SRS Medical Systems Inc-医療機器分野:企業M&A・提携分析
    Summary SRS Medical Systems Inc (SRS Medical) is a medical device company that designs, manufactures and markets diagnostics and disposable products. The company offers spanner, urocuff test systems, urodynamic systems, uroflows, uroscan bladder ultrasound systems and disposables. Its disposables co …
  • My Health Direct Inc:医療機器:M&Aディール及び事業提携情報
    Summary My Health Direct Inc (MHD) is a healthcare technology company that offers web-based solutions for the management of healthcare appointments. The company helps clients in achieving incremental revenue growth and real-time cost containment savings. It offers products such as consumer direct an …
  • Meridian Energy Limited:企業の戦略・SWOT・財務情報
    Meridian Energy Limited - Strategy, SWOT and Corporate Finance Report Summary Meridian Energy Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • PT Hanjaya Mandala Sampoerna Tbk. (HMSP):企業の財務・戦略的SWOT分析
    PT Hanjaya Mandala Sampoerna Tbk. (HMSP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Interstate Hotels & Resorts Inc:戦略・SWOT・企業財務分析
    Interstate Hotels & Resorts Inc - Strategy, SWOT and Corporate Finance Report Summary Interstate Hotels & Resorts Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Republic National Distributing Company:戦略・SWOT・企業財務分析
    Republic National Distributing Company - Strategy, SWOT and Corporate Finance Report Summary Republic National Distributing Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Human Care HC AB:企業の戦略的SWOT分析
    Human Care HC AB - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Energiequelle GmbH-エネルギー分野:企業M&A・提携分析
    Summary Energiequelle GmbH (Energiequelle) is a renewable energy company that provides turnkey system services to wind, biogas, and solar energy projects. Its offerings include planning and construction services: identification of project site, negotiation, and construction of project; and grid conn …
  • Patterson-UTI Energy Inc (PTEN):石油・ガス:M&Aディール及び事業提携情報
    Summary Patterson-UTI Energy Inc (Patterson) is an oilfield service provider. It offers onshore contract drilling and pressure pumping services to oil and gas exploration and production companies. The company offers pressure pumping services such as well stimulation and cementing for completion of n …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆